About 670,000 results
Open links in new tab
Press Releases | Gilead - Gilead Sciences
Gilead’s Twice-Yearly Lenacapavir Demonstrated 100% ... - Gilead Sciences
Newsroom | Gilead - Gilead Sciences
Gilead’s Twice-Yearly Lenacapavir Demonstrated 100% Efficacy …
Gilead Sciences Expands Liver Portfolio With Acquisition of …
Gilead Sciences to Acquire MiroBio
Gilead Sciences Announces Fourth Quarter and Full Year 2023 …
Gilead PrEP lenacapavir succeeds in Phase 3 trial - CNBC
Gilead Sciences Announces Fourth Quarter and Full Year 2022 …
Gilead Sciences Announces Second Quarter 2022 Financial Results